Stock listing
OTC:LADX LadRx Corporation Stock
Follow LadRx Corporation into a list and get an email when it puts out news.
Share price · OTC:LADX
$0.0003 USD 0.0000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.0003 – $0.0003 USDNov 20, 2026
- Volume
- 1,040 sharesNov 20, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- Traded on an average day
- $0 USDMedian day 0 shares · 17 days with no trades · last 3 months, Sep 24, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Sep 24, 2026 – Nov 20, 2026 · OTC:LADX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 1,040 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 1,909 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 3,003 | |
| $0.0003 | 0.0000 | 0.0% | $0.0003 | $0.0003 | $0.0003 | 0 | |
| $0.0003 | +0.0001 | +50.0% | $0.0003 | $0.0003 | $0.0003 | 1,176 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 342 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 0 | |
| $0.0002 | — | — | $0.0002 | $0.0002 | $0.0002 | 140 |
Splits
4 splits since 1996 · OTC:LADX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-100 | Consolidation | |
| 1-for-6 | Consolidation | |
| 1-for-7 | Consolidation | |
| 1-for-4 | Consolidation |
- Ticker
- OTC:LADX
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
LadRx Corporation on 6ix
- Decks
- 7 decks · latest March 2025
Valuation
price Nov 20, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.06
Events
| Quarter | Results |
|---|---|
| Q1 2025 | May 13, 2025 · Before open |
| Q4 2024 | Mar 25, 2025 · Before open |
| Q3 2024 | Nov 12, 2024 · Before open |
| Q2 2024 | Aug 14, 2024 · Before open |
| Q1 2024 | May 15, 2024 · Before open |
| Q4 2023 | Mar 27, 2024 · Before open |
| Q3 2023 | Nov 14, 2023 · Before open |
| Q2 2023 | Aug 14, 2023 · Before open |
| Q1 2023 | May 15, 2023 · Before open |
| Q4 2022 | Mar 20, 2023 · Before open |
All 17 quarters
| Quarter | Results |
|---|---|
| Q3 2022 | Nov 10, 2022 · Before open |
| Q2 2022 | Aug 11, 2022 · After close |
| Q1 2022 | Apr 1, 2022 |
| Q3 2021 | Nov 11, 2021 |
| Quarter to Jun 30, 2021 | Aug 24, 2021 |
| Quarter to Mar 31, 2021 | May 13, 2021 |
| Quarter to Dec 31, 2020 | Mar 26, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2025) | Investor deck | 20 slides | March 2025 |
| Investor Presentation (June 2024) | Investor deck | 20 slides | June 2024 |
| Investor Presentation (February 2024) | Investor deck | 16 slides | February 2024 |
| Investor Presentation (July 2023) | Investor deck | 16 slides | July 2023 |
| Investor Presentation (January 2023) | Investor deck | 20 slides | January 2023 |
| Investor Presentation (November 2022) | Investor deck | 20 slides | November 2022 |
| Investor Presentation (September 2022) | Investor deck | 20 slides | September 2022 |
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 250.0K |
| Research and development | 772.7K | 279.5K | 0 | 20.4K | 799.6K | 403.0K | 388.8K |
| Selling, general and administrative | 2.85M | 3.53M | 4.54M | 5.97M | 6.00M | 7.44M | 8.08M |
| Operating income | -3.62M | -3.82M | -4.56M | -5.98M | -6.83M | -7.86M | -8.25M |
| Depreciation and amortization | 5.71K | 11.8K | 195.4K | 197.3K | 230.1K | 20.7K | 29.4K |
| EBITDA | -3.62M | -3.81M | -4.36M | -5.78M | -6.60M | -7.84M | -8.22M |
| Interest expense | 0 | 1.72M | |||||
| Income before tax | -1.59M | 400.4K | -4.20M | -13.2M | -6.70M | -7.52M | -9.08M |
| Income tax | 800 | 800 | 800 | ||||
| Net income | -1.59M | 400.4K | -4.20M | -13.2M | -6.70M | -7.16M | -12.7M |
| Earnings per share, basic | -3.21 | 0.81 | -0.09 | -0.34 | -0.18 | -0.21 | -0.38 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 759.7K | 2.07M | 1.37M | 6.77M | 10.0M | 16.1M | 21.4M |
| Receivables | 0 | 200.0K | 325.1K | 7.63K | 148.5K | ||
| Current assets | 837.0K | 2.26M | 2.00M | 8.28M | 11.4M | 17.2M | 22.5M |
| Property, plant and equipment | 235.3K | 430.0K | 620.2K | 42.9K | 44.3K | ||
| Goodwill | 0 | ||||||
| Total assets | 839.5K | 2.31M | 2.25M | 8.73M | 12.1M | 17.3M | 22.9M |
| Accounts payable | 1.06M | 1.20M | 975.9K | 1.47M | 1.40M | 887.8K | 1.23M |
| Current liabilities | 2.26M | 2.20M | 2.19M | 3.73M | 2.77M | 2.05M | 2.56M |
| Total liabilities | 2.26M | 2.20M | 2.22M | 3.95M | 3.19M | 2.05M | 2.56M |
| Shareholders' equity | -1.42M | 107.4K | 25.7K | 4.78M | 8.87M | 15.2M | 20.4M |
| Shares outstanding | 495.1K | 495.1K | 45.0M | 38.8M | 36.5M | 33.6M | 33.6M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.31M | 1.01M | -4.83M | -12.3M | -6.14M | -5.72M | -10.9M | ||
| Capital spending | 0 | 0 | -766 | -7.00K | -25.9K | -24.7K | -11.5K | 0 | 0 |
| Free cash flow | -1.31M | 1.01M | -4.83M | -12.3M | -6.17M | -5.74M | -10.9M | ||
| Cash from investing | -766 | -7.00K | -25.9K | 475.5K | -11.5K | ||||
| Cash from financing | 0 | -318.8K | -561.4K | 9.08M | 39.0K | 39.0K | -5.25M | ||
| Dividends paid | 0 | -68.8K | -561.4K | -171.7K | -171.7K | -171.7K | -171.7K | ||
| Share buybacks | 0 | -250.0K | 0 | ||||||
| Change in cash | -1.31M | 695.1K | -5.39M | -3.23M | -6.13M | -5.24M | -16.1M |
Cap table
Built by 6ix from LadRx Corporation’s releases
- Common shares
- 495,092
- Fully diluted
- 495,092
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 495,092 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 495,092 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jennifer Simpson Other companies: Eagle Pharmaceuticals, Inc. (Board Member, Lead Independent Director of the Board · Since at least Aug 28, 2019); Panbela Therapeutics, Inc. (President and CEO, Director · Mar 30, 2021 – Oct 1, 2024 · Past); Delcath Systems, Inc. (President and CEO, Director · Mar 23, 2012 – May 6, 2020 · Past) | Director · Jan 15, 2024 – Jan 15, 2024 · Past |
| Joel K Caldwell | Director · Jan 15, 2024 – Jan 15, 2024 · Past |
| John Y Caloz | Chief Financial Officer · Jan 15, 2024 – Jan 15, 2024 · Past |
| Stephen Snowdy | Chief Executive Officer · Jan 15, 2024 – Jan 15, 2024 · Past |
Log in to ask 6ix AI your own questions about LadRx Corporation.